According to Chenkang Technology's URC literature reports, there are several points worth sharing about the "5-hydroxyindoleacetic acid detection reagent":
1. Health Status of Screened Population
Out of over 4,000 people screened with 5-hydroxyindoleacetic acid, 47.78% were identified as sub-healthy, indicating potential risks of various diseases. This reflects the reagent's ability to widely detect underlying health issues.
2. Early Cancer Screening Capability
Out of 111 cases with initial positive urine tests, further examination and re-examination identified 1 case of liver cancer. This demonstrates the reagent's potential for detecting early-stage tumors.
3. Disease Risk Warning
5-hydroxyindoleacetic acid testing can indicate risks of diseases in multiple systems including digestive, urogenital, and respiratory, which is highly significant for disease prevention.
4. Convenience and Rapidity
As a non-invasive, economical, convenient and rapid testing method, the 5-hydroxyindoleacetic acid reagent offers operability advantages in large-scale population screening.
5. Development History of Tumor Screening Reagents
From the earliest report in 1994 to nearly 30 years now, the 5-hydroxyindoleacetic acid detection reagent has undergone continuous clinical application and evaluation, accumulating substantial data and experience to lay the foundation for future improvement and optimization.
The potential of this reagent in early tumor detection, disease risk warning, and large-scale health screening makes it an absolutely breakthrough screening technology.
